Monthly Archives: April 2013

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

Credit: Andrea Sivarsson

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated by David Kappos, will be held in Chicago on Monday April 22nd from 2:30-3:30pm in room S404A at this year’s BIO International Convention. Former Undersecretary of Commerce for Intellectual Property and USPTO Director David J. Kappos will moderate a panel of legal experts who will discuss recent developments in the area of patent utility and its implications for biopharmaceutical innovation.  Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Cranial Connections: Ontario’s Brain Research is Hardwired for Success

Moridi

Ontario has long been a leader in life sciences research and technology with brain exploration now taking centre-stage. Most recently, the provincial government committed $100 million to the Ontario Brain Institute, (OBI).  An independent nonprofit formed in 2010, the OBI  will help researchers and business leaders develop new treatments for neurological conditions ranging from Alzheimer’s and Parkinson’s to intractable epilepsy, cerebral palsy, autism and attention deficit and hyperactivity disorder. Headquartered in Toronto – a region that Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The Week Ahead for Partnering

Partnering

As mentioned in our twitter feed, BIO Business Forum and Exhibitor Partnering has surpassed the number of requests in the system over last year’s totals. Over 130,000 partnering meeting requests are off in cyberspace, and close to 22,000 meetings already scheduled. This includes about 4,900 exhibitor partnering meetings, which is another stat beating last year’s numbers. We’ve been excited about the addition of exhibitor partnering, and it’s been great to see the adoption by the exhibitors themselves. Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Jay Keasling Wins BIO’s George Washington Carver Award

Carver Award

BIO announced today that it will honor Jay Keasling, a professor of biochemical engineering at University of California, Berkley; associate laboratory director at Lawrence Berkeley National Laboratory; CEO of the Joint BioEnergy Institute; and Director of Synthetic Biology Engineering Research Center, as the recipient of its 2013 George Washington Carver Award for innovation in industrial biotechnology. The award honors the vision of Carver, an originator of the “chemurgy” movement who, more than a century ago, achieved world Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The UK at BIO

The UK at BIO

There are more than 400 delegates from the UK attending the 2013 BIO International Convention. These include delegates from four innovative life science companies – Abcodia, Critical Pharmaceuticals, Nanomerics, and PsiOxus Therapeutics – who won the recent UK Trade and Investment (UKTI) Innovation Competition and will showcase their technologies to an international audience in Chicago. The UK presence at the convention will be centred on the UK pavilion (stand 4441) hosted by the BioIndustry Association (BIA) Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,